Indegene (NSE:INDGN) Other Current Payables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDGN Indegene Ltd NSE:INDGN
49 GF Score
Price ₹565.40
! 6 Warning Signs
View Full Analysis

What is Indegene Other Current Payables?

Indegene NSE:INDGN -0.39% 49 Other Current Payables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:INDGN with a GF Score™ of 49/100. The stock has 6 warning signs investors should review.

Indegene's Other Current Payables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Indegene's quarterly Other Current Payables increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹507 Mil) but then declined from Mar. 2026 (₹507 Mil) to Jun. 2026 (₹0 Mil).

Indegene's annual Other Current Payables increased from Mar. 2024 (₹352 Mil) to Mar. 2025 (₹598 Mil) but then declined from Mar. 2025 (₹598 Mil) to Mar. 2026 (₹507 Mil).

Indegene Other Current Payables Related Terms

Indegene Other Current Payables Historical Data

* Premium members only.

The historical data trend for Indegene's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indegene Other Current Payables Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial 184.33 379.22 352.00 598.00 507.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 507.00 0.00
NSE:INDGN
49GF Score
Indegene Ltd NSE:INDGN
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indegene Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0 Mil mean?
Indegene (NSE:INDGN) has a Other Current Payables of ₹0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Indegene and its competitors.
Is Indegene's Other Current Payables too high?
Indegene's current Other Current Payables is ₹0 Mil. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's Other Current Payables compare to VEEV and BTSG?
Indegene's Other Current Payables of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Healthcare Providers & Services company?
A good Other Current Payables depends on the Healthcare Providers & Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Indegene and its competitors. Indegene's current Other Current Payables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current Other Current Payables of ₹0 Mil. The current Other Current Payables is ₹0 Mil. Indegene's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current Other Current Payables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indegene Business Description

Other Exchanges 544172:India
Address Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score

Get the complete analysis for NSE:INDGN

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹565.40
Price